奥密克戎与德尔塔变异株大流行期间主要因COVID-19住院患者的死亡风险——美国,2020年4月至2022年6月
CDC利用大型医院行政数据库,评估德尔塔(2021年7—10月)、早期奥密克戎(2022年1—3月)和后期奥密克戎(2022年4—6月)期间主要因COVID-19住院患者的院内死亡风险。早期和后期奥密克戎期粗死亡风险分别为13.1/100和4.9/100,均低于德尔塔期的15.1/100(p<0.001);调整后死亡风险在奥密克戎各期也低于德尔塔期。后期奥密克戎期81.9%的院内死亡发生在≥65岁成人,73.4%发生在有3种及以上基础疾病者。
要点
- 早期奥密克戎期粗死亡风险13.1/100,后期4.9/100,均低于德尔塔期15.1/100(p<0.001)。
- 调整后死亡风险在奥密克戎两期均低于德尔塔期,各亚组aMRD和aMRR显著(p<0.05)。
- 后期奥密克戎期81.9%院内死亡为≥65岁成人,73.4%有≥3种基础疾病。
核心结论
- 主要因COVID-19住院患者的院内死亡风险在早期和后期奥密克戎期均低于德尔塔期,调整后结果一致。
- 接种疫苗、早期治疗和适当的非药物干预仍是预防COVID-19死亡的重要公共卫生优先事项,尤其对高风险人群。
研究设计与样本
- CDC利用大型医院行政数据库,评估德尔塔(2021年7—10月)、早期奥密克戎(2022年1—3月)和后期奥密克戎(2022年4—6月)期间主要因COVID-19住院患者的院内死亡风险。
- 计算模型估计的调整死亡风险差(aMRDs)和调整死亡风险比(aMRRs),比较早期和后期奥密克戎期与德尔塔期。
主要发现
- 粗死亡风险(cMR,每100例主要因COVID-19住院患者的死亡数)在早期奥密克戎期为13.1,后期奥密克戎期为4.9,均低于德尔塔期的15.1(p<0.001)。
- 调整后死亡风险在奥密克戎两期均低于德尔塔期,对≥18岁、男性和女性、所有种族和民族组、有和无残疾者以及有一种或以上基础疾病者,aMRDs和aMRRs显著(p<0.05)。
- 后期奥密克戎期,81.9%的院内死亡发生在≥65岁成人,73.4%发生在有3种或以上基础疾病者。
临床怎么用
- 接种疫苗、早期治疗和适当的非药物干预仍是预防COVID-19死亡的重要公共卫生优先事项,尤其对高风险人群。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The risk for COVID-19-associated mortality increases with age, disability, and underlying medical conditions (1). Early in the emergence of the Omicron variant of SARS-CoV-2, the virus that causes COVID-19, mortality among hospitalized COVID-19 patients was lower than that during previous pandemic peaks (2-5), and some health authorities reported that a substantial proportion of COVID-19 hospitalizations were not primarily for COVID-19-related illness,* which might account for the lower mortality among hospitalized patients. Using a large hospital administrative database, CDC assessed in-hospital mortality risk overall and by demographic and clinical characteristics during the Delta (July-October 2021), early Omicron (January-March 2022), and later Omicron (April-June 2022) variant periods† among patients hospitalized primarily for COVID-19. Model-estimated adjusted mortality risk differences (aMRDs) (measures of absolute risk) and adjusted mortality risk ratios (aMRRs) (measures of relative risk) for in-hospital death were calculated comparing the early and later Omicron periods with the Delta period. Crude mortality risk (cMR) (deaths per 100 patients hospitalized primarily for COVID-19) was lower during the early Omicron (13.1) and later Omicron (4.9) periods than during the Delta (15.1) period (p<0.001). Adjusted mortality risk was lower during the Omicron periods than during the Delta period for patients aged ≥18 years, males and females, all racial and ethnic groups, persons with and without disabilities, and those with one or more underlying medical conditions, as indicated by significant aMRDs and aMRRs (p<0.05). During the later Omicron period, 81.9% of in-hospital deaths occurred among adults aged ≥65 years and 73.4% occurred among persons with three or more underlying medical conditions. Vaccination, early treatment, and appropriate nonpharmaceutical interventions remain important public health priorities for preventing COVID-19 deaths, especially among persons most at risk.
引用
- Adjei S, Hong K, Molinari NM, et al. Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods - United States, April 2020-June 2022. MMWR Morb Mortal Wkly Rep. 2022. PMID: 36107788. doi:10.15585/mmwr.mm7137a4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。